• Find us on Facebook
  • Follow BMJ OnExamination on Twitter

News Article Details

EARLY RELEASE: Effect of Rosiglitazone on the Risk of Myocardial Infarction and...

NEJM - 21/05/2007 16:58:22

Background Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined. Methods We conducted searches of ...

Members comments

Comment on this article:

Sign in or register to comment on this story


    © 2015 BMJ Publishing Group Ltd . All rights reserved.